Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
She was most recently a correspondent at Kaiser Health News, where she covered drug prices and specialized in data reporting for its enterprise team. She's reported on how tainted drugs can reach consumers, how companies take advantage of rare disease drug rules and how FDA-approved generics often don't make it to market. She's also tracked pharmaceutical dollars to patient advocacy groups and members of Congress. Her work has won the National Press Club's Joan M. Friedenberg Online Journalism Award, the National Institute for Health Care Management's Digital Media Award and a health reporting award from the Society for Advancing Business Editing and Writing.
Lupkin graduated from Boston University. She's also worked for ABC News, VICE News, MedPage Today and The Bay Citizen. Her internship and part-time work includes stints at ProPublica, The Boston Globe, The Boston Herald, The New England Center for Investigative Reporting and WCVB.
-
Under Trump administration deals to lower drug prices, pharmaceutical companies are offering some of their drugs at discounted prices through a new website called TrumpRx.gov. -
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026. -
Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the deals with the Trump administration on some drug prices versus others.
-
The Wegovy pill approved in December arrived at pharmacies nationwide on Monday. Patients now have a new way to take the weight loss medication.
-
Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers. -
There's a new pill and new ways to pay for the weight-loss drugs known as GLP-1s.
-
Mail theft can happen around the holidays, but sometimes, instead of getting a new iPad, the thief swipes a mail order medicine. Here's what to do about it. -
Food and Drug Administration officials say they will ratchet up requirements for vaccine studies, citing concerns about COVID shots for kids. But public health experts question the agency's analysis. -
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia. -
Instead of weekly injections, patients will soon be able to swallow a daily pill to lose weight. Novo Nordisk's pill form of Wegovy is the first to gain Food and Drug Administration approval.
